The Depakote lawsuit is active heading into 2026, with hundreds of claims pending against Abbott Laboratories and AbbVie for birth defects and serious side effects tied to the drug. If you or your child was harmed by Depakote, you may be entitled to significant compensation.
This article covers everything you need to know about the Depakote litigation right now. You’ll find current settlement estimates, payout breakdowns per person, eligibility requirements, and filing deadlines.
One fact that surprises most people: the FDA added its strongest warning to Depakote for pregnancy risks back in 2011, but Abbott had internal data showing dangers years before that. Thousands of families say they were never properly warned.
Whether you’re a parent of a child with birth defects or an adult who suffered liver damage or other injuries, this guide walks you through every angle of the 2026 legal picture.
Depakote Lawsuit 2026: What You Need to Know Right Now
The Depakote lawsuit in 2026 involves ongoing claims that Abbott Laboratories and its successor AbbVie failed to warn patients and doctors about serious risks tied to the drug, especially during pregnancy. These cases are not new, but they remain very much alive.
Depakote (divalproex sodium) is an anticonvulsant prescribed for epilepsy, bipolar disorder, and migraine prevention. It’s been on the market since the 1980s. The core allegation in most lawsuits is straightforward: the manufacturers knew Depakote caused birth defects and other severe injuries but did not adequately disclose those risks.
As of early 2026, cases continue to move through federal and state courts. Some have already gone to trial. Others are in settlement negotiations.
| Detail | Info |
|---|---|
| Drug Name | Depakote (divalproex sodium) |
| Manufacturer | Abbott Laboratories / AbbVie |
| Primary Allegations | Failure to warn about birth defects and serious side effects |
| Court | Federal MDL in Southern District of Illinois |
| Case Status as of 2026 | Active, with trials and settlements ongoing |
The stakes are high for both sides. Abbott has already lost several bellwether trials, with juries awarding millions to individual plaintiffs. But the company has also won some cases, making each claim’s outcome uncertain.
If you took Depakote and experienced harm, 2026 is a critical window. Statutes of limitations vary by state, and waiting too long could permanently block your claim.
Depakote Lawsuit Update for 2026
The latest Depakote lawsuit update for 2026 shows continued movement in both federal multidistrict litigation and individual state court cases. Several bellwether trials in previous years set important precedents that are shaping current settlement discussions.
In past bellwether trials, juries returned verdicts both for and against Abbott. One notable case resulted in a $15 million verdict for a child born with birth defects after the mother took Depakote during pregnancy. Another trial ended in a defense verdict for Abbott, showing that outcomes depend heavily on individual case facts.
Throughout 2025, attorneys on both sides engaged in mediation sessions aimed at resolving large groups of cases. Those discussions are expected to carry into 2026.
Key updates to watch for in 2026:
- New trial dates for individual cases that did not settle
- Potential global settlement offers covering groups of birth defect claims
- Statute of limitations rulings that could affect late-filed cases
- New expert testimony on the link between valproic acid and specific birth defects
The litigation is far from over. New plaintiffs continue to file claims as more families learn about the connection between Depakote and childhood disabilities. If you’ve been considering filing, now is a good time to evaluate your options.
Depakote Settlement Amounts: What Payouts Look Like
Depakote settlement amounts vary widely based on the type and severity of injury, but individual payouts in birth defect cases have ranged from tens of thousands of dollars to several million. There is no single fixed number because each claim is evaluated on its own facts.
A few data points help paint the picture. In one bellwether trial, a jury awarded $15 million to a single plaintiff. In another, the award was $38 million before being reduced on appeal. These large verdicts are rare, though. Most cases that settle do so for significantly less than a trial verdict.
| Settlement Tier | Estimated Range | Typical Injury |
|---|---|---|
| Tier 1 (Severe) | $500,000 to $5,000,000+ | Major neural tube defects, spina bifida |
| Tier 2 (Moderate) | $100,000 to $500,000 | Heart defects, cleft palate, limb abnormalities |
| Tier 3 (Lower) | $25,000 to $100,000 | Minor congenital abnormalities, cognitive delays |
| Adult Injury Claims | $10,000 to $250,000 | Liver damage, pancreatitis |
These ranges are estimates based on past verdicts, reported settlements, and attorney projections. Your actual payout depends on medical records, proof of Depakote use during pregnancy, and the specific injury your child suffered.
It’s worth knowing that pharmaceutical companies often settle cases confidentially. That means the real numbers from settled claims are often kept out of public view.
Key Takeaway: The Depakote lawsuit remains active in 2026 with settlement amounts ranging from $25,000 to over $5 million depending on the severity of injury, and new filings are still being accepted.
Depakote Lawsuit Payout Per Person
The Depakote lawsuit payout per person depends on the specific injury, the strength of medical evidence, and whether the case goes to trial or settles. There is no flat “per person” amount that applies to everyone.
Think of it like car insurance claims. A fender bender pays out differently than a totaled vehicle with injuries. Same principle here. A child born with spina bifida after Depakote exposure will receive a very different payout than someone with a minor congenital anomaly.
Here’s what drives individual payout amounts:
- Type of birth defect: Neural tube defects like spina bifida carry the highest value
- Severity of disability: Lifelong care needs increase compensation significantly
- Medical documentation: Strong records showing Depakote use during the first trimester matter most
- Economic damages: Lost wages for caregiving parents, medical bills, therapy costs
- Pain and suffering: Courts factor in emotional and physical suffering for both the child and parents
Some attorneys estimate that the average settlement per person in moderate birth defect cases falls between $150,000 and $500,000. Severe cases can push well past $1 million.
Punitive damages are also possible if a jury finds that Abbott acted with reckless disregard for patient safety. Those awards can add millions to a verdict but are less common in settlements.
Who Qualifies for the Depakote Lawsuit
You may qualify for the Depakote lawsuit if you took Depakote during pregnancy and your child was born with a birth defect, or if you personally suffered a serious side effect like liver damage or pancreatitis from the drug.
The eligibility criteria break down into two main groups: pregnancy-related claims and adult injury claims.
For birth defect claims, you generally qualify if:
- You took Depakote (or generic valproic acid) during pregnancy
- Your child was born with a congenital defect such as spina bifida, heart defects, cleft palate, or cognitive impairments
- You can provide medical records showing Depakote was prescribed and taken during pregnancy
For adult injury claims, you may qualify if:
- You took Depakote for epilepsy, bipolar disorder, or migraines
- You developed serious liver damage, pancreatitis, or other severe side effects
- Your injuries required hospitalization or ongoing medical treatment
| Qualification Factor | Birth Defect Claims | Adult Injury Claims |
|---|---|---|
| Drug Used | Depakote, Depakene, or generic valproic acid | Same |
| Timing | During pregnancy | Any period of use |
| Injury Required | Congenital birth defect | Liver failure, pancreatitis, other serious harm |
| Proof Needed | Prescription records, medical records | Prescription records, medical records |
You do not need to have filed an FDA adverse event report. You do not need to have stopped taking the drug. The key requirements are proof of use and proof of injury.
Depakote Birth Defect Lawsuit Explained
The Depakote birth defect lawsuit is the largest category of claims in this litigation, centered on the allegation that Abbott knew valproic acid caused fetal harm but failed to adequately warn pregnant women and their doctors. Hundreds of families have filed these claims.
The science behind these lawsuits is well established. Valproic acid crosses the placental barrier and interferes with fetal development, particularly during the first trimester when organs are forming. The risk is not small. Studies have shown that 10% to 15% of babies exposed to valproic acid in utero are born with major congenital malformations. That rate is dramatically higher than the general population risk of about 3%.
The most common birth defects alleged in Depakote lawsuits include:
- Spina bifida (incomplete closure of the spinal column)
- Heart defects (atrial and ventricular septal defects)
- Cleft palate and cleft lip
- Hypospadias (urethral abnormality in boys)
- Limb defects
- Cognitive and developmental delays
- Fetal valproate syndrome (a pattern of facial and developmental abnormalities)
Abbott’s defense has centered on arguing that the warnings provided to doctors were adequate and that the benefits of seizure control during pregnancy sometimes outweigh the risks. Plaintiffs counter that Abbott buried unfavorable safety data and marketed Depakote aggressively without proper risk disclosures.
The FDA classified Depakote as Pregnancy Category D in 2006 and later added a black box warning in 2011 specifically about neural tube defects. Many plaintiffs took the drug before those warnings were strengthened.
Depakote and Birth Defects: The Medical Evidence
Depakote and birth defects are linked through decades of clinical research showing that valproic acid is one of the most teratogenic (birth-defect-causing) prescription drugs available. The medical evidence is not disputed by the scientific community.
The connection was first suspected in the 1980s and has been confirmed by multiple large-scale studies since then. Research published in major medical journals has consistently shown that valproic acid exposure during pregnancy carries a significantly elevated risk of major congenital malformations.
Key studies include:
- The North American Antiepileptic Drug Pregnancy Registry: Found that Depakote carried the highest risk of birth defects among all commonly used antiepileptic drugs
- A 2010 New England Journal of Medicine study: Reported a malformation rate of approximately 10.7% for babies exposed to valproic acid, compared to 2.9% for unexposed babies
- European surveillance studies: Confirmed elevated risks of neural tube defects, cardiac malformations, and skeletal abnormalities
Beyond structural birth defects, research has also linked prenatal Depakote exposure to:
- Lower IQ scores in children
- Increased risk of autism spectrum disorder
- Behavioral and learning difficulties
The evidence is strong enough that medical guidelines now recommend avoiding valproic acid during pregnancy whenever possible. Alternative anticonvulsants with lower teratogenic risk are typically preferred.
For lawsuit purposes, this body of research forms the foundation of every birth defect claim. Plaintiffs argue that Abbott had access to this data early and chose profits over patient safety.
Key Takeaway: Anyone who took Depakote during pregnancy and had a child with birth defects, or any adult who suffered serious side effects, may qualify to file a claim and receive compensation that could range from $25,000 to several million dollars.
Depakote Side Effects Lawsuit Claims
Depakote side effects lawsuits cover a range of serious injuries beyond birth defects, including liver damage, pancreatitis, and neurological problems in adult patients. These claims argue that Abbott failed to warn about the full scope of risks.
While birth defect cases get the most attention, adults who took Depakote and suffered severe side effects have their own grounds for legal action. The drug carries several FDA warnings for potentially life-threatening conditions.
Common side effects cited in lawsuits include:
- Hepatotoxicity (liver damage): Can be fatal, especially in children under age 2. The FDA requires regular liver function monitoring for Depakote patients
- Pancreatitis: Inflammation of the pancreas that can become life-threatening. Cases have occurred after both short-term and long-term use
- Suicidal thoughts and behavior: The FDA issued a class-wide warning for all antiepileptic drugs in 2008, noting an increased risk of suicidal ideation
- Thrombocytopenia: Dangerously low platelet counts that increase bleeding risk
- Hyperammonemia: Elevated ammonia levels in the blood that can cause brain damage
| Side Effect | Severity | FDA Warning Level |
|---|---|---|
| Liver failure | Life-threatening | Black box warning |
| Pancreatitis | Life-threatening | Black box warning |
| Birth defects | Permanent | Black box warning |
| Suicidal behavior | Serious | Class-wide warning |
| Thrombocytopenia | Serious | Standard warning |
Adult side effects cases tend to have lower payouts than birth defect cases. But severe liver failure or pancreatitis requiring hospitalization and surgery can still result in substantial compensation. The strength of these claims depends on whether alternative causes can be ruled out.
Is There a Depakote Class Action Lawsuit
There is no Depakote class action lawsuit in the traditional sense. The Depakote litigation is structured as a mass tort and multidistrict litigation (MDL), which means each case is handled individually rather than as one group action.
People often confuse class actions with mass torts. Here’s the simple difference: in a class action, one lawsuit covers everyone and the payout is split equally. In a mass tort, every plaintiff files their own case with their own evidence, and each payout reflects the specific harm that person suffered.
The Depakote cases were consolidated into MDL No. 2677 in the U.S. District Court for the Southern District of Illinois. This consolidation is for pretrial efficiency only. Each case retains its individual identity.
This structure actually benefits plaintiffs in most situations. A child born with severe spina bifida should not receive the same payout as a child with a minor anomaly. The mass tort format allows for individualized justice.
Some attorneys may use the term “class action” loosely in their marketing, but technically, no Depakote class action has been certified by any court.
Depakote Class Action Lawsuit vs. Mass Tort
The Depakote class action lawsuit label is a misnomer because the actual legal process is a mass tort, and understanding this distinction matters for anyone considering filing. Mass torts provide individual settlements while class actions distribute a single pool of money.
| Feature | Class Action | Mass Tort (Depakote) |
|---|---|---|
| Number of lawsuits | One lawsuit for all | Individual lawsuits per plaintiff |
| Settlement distribution | Equal share for all members | Based on individual injury severity |
| Plaintiff involvement | Minimal, handled by lead plaintiff | Each plaintiff works with their own attorney |
| Payout potential | Usually smaller per person | Can be much larger per person |
| Opt-in required | Usually opt-out (automatic inclusion) | Must actively file a claim |
For Depakote plaintiffs, the mass tort structure means your compensation reflects your specific situation. If your child needs lifelong medical care, your case is valued very differently from someone with a less severe injury.
The downside is that mass torts take longer. Each case needs its own evidence package, medical expert review, and legal assessment. But the payoff for patience can be significantly higher than what a class action would deliver.
If someone tells you to “join the Depakote class action,” what they really mean is filing an individual claim within the mass tort litigation. The legal outcome is the same. The terminology is just different.
Depakote Lawsuit Eligibility Requirements
Depakote lawsuit eligibility requires proof that you took Depakote (or generic valproic acid), suffered a qualifying injury, and can file within your state’s statute of limitations. Meeting all three criteria is essential for a valid claim.
The three pillars of eligibility:
1. Proof of Depakote Use
You need medical records, pharmacy records, or prescription history showing that you or the injured person took Depakote, Depakote ER, Depakene, or generic divalproex sodium or valproic acid. Insurance records and doctor’s notes can also serve as evidence.
2. Qualifying Injury
Your injury must be a recognized side effect of Depakote. For birth defect claims, this means a child born with a congenital malformation after prenatal exposure. For adult claims, this means liver failure, pancreatitis, or other serious documented harm.
3. Statute of Limitations
You must file within the time window allowed by your state’s law. This varies from 1 to 6 years depending on the state and when you discovered (or should have discovered) the connection between Depakote and your injury.
| Eligibility Requirement | What You Need |
|---|---|
| Proof of Drug Use | Prescription records, pharmacy receipts, medical charts |
| Qualifying Injury | Diagnosed birth defect or serious side effect |
| Filing Deadline | Within state statute of limitations (varies by state) |
| Causation | Medical evidence linking Depakote to the injury |
You do not need to prove that Depakote was the only possible cause. You need to show it was a substantial contributing factor. Your attorney and medical experts will handle that analysis.
Key Takeaway: The Depakote litigation is a mass tort (not a class action), which means every plaintiff files an individual case and receives compensation based on their specific injuries, with eligibility requiring proof of drug use, a qualifying injury, and timely filing.
Depakote Liver Damage Lawsuit Claims
Depakote liver damage lawsuits involve adult patients who developed hepatotoxicity, or toxic liver injury, while taking the drug. The FDA requires a black box warning on Depakote specifically about the risk of fatal liver failure.
Liver damage from Depakote can range from elevated liver enzymes (detectable through blood tests) to complete liver failure requiring transplant. The risk is highest during the first six months of treatment and in children under age 2.
The drug’s own prescribing information warns about hepatic fatalities. Despite this, many lawsuits allege that doctors were not given clear enough guidance about monitoring protocols and risk factors. Some patients say they received no liver function testing at all during their treatment.
Signs of Depakote-related liver damage include:
- Jaundice (yellowing of the skin and eyes)
- Unexplained fatigue and weakness
- Abdominal pain and swelling
- Dark urine and pale stools
- Loss of appetite and nausea
- Abnormal blood clotting
If you experienced liver damage while taking Depakote and required hospitalization, surgery, or a transplant, your case may carry significant value. Cases involving liver failure that led to death may allow surviving family members to file a wrongful death claim.
These adult liver damage claims are less common than birth defect cases but can still result in meaningful compensation. The key evidence includes medical records showing Depakote use, liver function test results, and documentation that alternative causes (like alcohol use or hepatitis) were ruled out.
Depakote Lawsuit for Adults
The Depakote lawsuit for adults covers individuals who were prescribed the drug for epilepsy, bipolar disorder, or migraine prevention and then suffered serious adverse effects. These claims exist separately from the birth defect litigation.
Many people assume the Depakote lawsuit only involves pregnant women and babies. That’s not accurate. Adults of all ages and genders have filed claims based on injuries they personally experienced while taking the medication.
Types of adult Depakote claims include:
- Liver failure cases: As discussed above, hepatotoxicity is a recognized and potentially fatal risk
- Pancreatitis cases: The FDA warns that Depakote can cause life-threatening pancreatitis at any point during treatment
- Suicidal ideation cases: Some patients developed suicidal thoughts or behaviors after starting Depakote
- Polycystic ovary syndrome (PCOS): Some women who took Depakote for conditions other than pregnancy developed hormonal disruptions
- Weight gain and metabolic syndrome: While less likely to support a standalone lawsuit, these effects can be part of a broader claim
| Adult Claim Type | Key Evidence Needed |
|---|---|
| Liver damage | Liver function tests, biopsy results, hospitalization records |
| Pancreatitis | ER records, imaging, enzyme levels |
| Suicidal behavior | Psychiatric records, timeline showing onset after starting Depakote |
| PCOS | Hormonal testing, ultrasound results |
Adult claims generally produce smaller settlements than birth defect cases because the injuries, while serious, are often treatable rather than permanent. But cases involving organ failure or death can still reach six or seven figures.
If you took Depakote and suffered harm, don’t assume your case doesn’t count because you weren’t pregnant. Talk to an attorney who handles pharmaceutical litigation.
Depakote MDL Status in 2026
The Depakote MDL (Multidistrict Litigation No. 2677) is housed in the U.S. District Court for the Southern District of Illinois and remains active as of 2026, with cases continuing to move through pretrial proceedings, settlement talks, and individual trial scheduling.
MDL is a federal court process that consolidates similar cases from across the country before one judge for efficiency. It handles discovery (evidence gathering), expert witness disputes, and procedural motions. But each case maintains its individual status for trial and settlement purposes.
Key facts about MDL No. 2677:
- Presiding Judge: The Honorable Nancy J. Rosenstengel oversees the litigation
- Location: U.S. District Court, Southern District of Illinois (East St. Louis)
- Number of Cases: Hundreds of individual cases have been filed within the MDL
- Bellwether Trials: Several have already been completed, with mixed results for both sides
- Current Phase: Ongoing settlement negotiations and individual case resolutions
The bellwether trial process is important because it tests how juries respond to the evidence. When plaintiffs win big verdicts, it pressures the manufacturer to settle remaining cases. When the defense wins, it gives Abbott leverage to push for lower settlements or fight cases at trial.
As of 2026, the MDL is in a mature phase. The initial discovery battles and expert challenges are largely resolved. The focus now is on resolving remaining cases through either settlement or trial.
How to File a Depakote Lawsuit
To file a Depakote lawsuit, you need to contact a pharmaceutical litigation attorney, gather your medical and prescription records, and have your case evaluated for eligibility. The filing process itself is handled by your legal team.
Filing a pharmaceutical lawsuit sounds intimidating, but the process is more straightforward than most people expect. Here’s how it typically works, step by step.
Step 1: Free Case Evaluation
Most attorneys who handle Depakote cases offer free consultations. You’ll share basic information about your Depakote use, the timeline, and the injuries involved. The attorney determines whether you have a viable claim.
Step 2: Gather Records
Your attorney will help you collect medical records, pharmacy records, and any documentation showing Depakote was prescribed and taken. For birth defect cases, records of the child’s diagnosis and treatment are essential.
Step 3: File the Complaint
Your attorney drafts and files a legal complaint, either in the MDL court or in a state court depending on your situation. You are the named plaintiff.
Step 4: Discovery and Case Building
Both sides exchange evidence. Your medical experts review records and prepare opinions on causation. This phase can take months to a year or more.
Step 5: Resolution
Your case either settles through negotiation or goes to trial. Most pharmaceutical cases settle before trial.
- Cost: Most attorneys work on contingency, meaning you pay nothing upfront. The attorney takes a percentage (typically 33% to 40%) of any recovery.
- Time Commitment: You may need to provide a deposition and answer written questions, but your attorney handles the heavy lifting.
Key Takeaway: Filing a Depakote lawsuit involves a free attorney consultation, medical record collection, and a complaint filed either in the federal MDL or state court, with no upfront cost under contingency fee arrangements.
Depakote Lawsuit Deadline for 2026
The Depakote lawsuit deadline varies by state because each state has its own statute of limitations for product liability and personal injury claims. There is no single national deadline, but waiting too long in any state will permanently bar your claim.
Most states set a filing window of 2 to 4 years from the date of injury or the date you discovered (or should have discovered) the connection between Depakote and your harm. This “discovery rule” is critical because many families did not learn about the Depakote risk until years after a child was born.
| State | Statute of Limitations | Discovery Rule |
|---|---|---|
| California | 2 years | Yes, from date of discovery |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 4 years | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
| Ohio | 2 years | Yes |
Important considerations for 2026:
- If your child was born with birth defects and is now approaching their teens or twenties, the statute may have already expired in some states unless the discovery rule applies
- Some states toll (pause) the statute of limitations for minors, meaning the clock doesn’t start until the child turns 18
- Federal MDL filing does not override state statute of limitations requirements
The safest approach is to have an attorney evaluate your specific timeline immediately. Even if you think you might be too late, the discovery rule or minor tolling provisions could keep your case alive.
Do not wait to find out. The deadline question is the one thing that can end your case before it starts, no matter how strong the evidence of harm.
Frequently Asked Questions
How much money can I get from a Depakote lawsuit?
Most birth defect claims settle between $100,000 and $5 million depending on severity.
Adult injury claims typically range from $10,000 to $250,000.
Your individual payout depends on the specific injury, medical evidence, and whether your case settles or goes to trial.
Is there a deadline to file a Depakote lawsuit in 2026?
Yes, every state has a statute of limitations that sets a filing deadline, typically 2 to 4 years from injury or discovery.
Some states pause the clock for minors, extending the deadline until the child reaches age 18.
Contact an attorney as soon as possible to confirm your state’s specific deadline.
Can adults file a Depakote lawsuit for side effects?
Yes, adults who took Depakote and suffered liver damage, pancreatitis, or other serious side effects can file individual claims.
These cases are separate from birth defect lawsuits but follow the same legal process.
Strong medical records linking the injury to Depakote use are essential.
Is the Depakote lawsuit a class action or mass tort?
The Depakote lawsuit is a mass tort, not a class action.
Each plaintiff files an individual case and receives a separate payout based on their injuries.
Cases are consolidated in MDL No. 2677 for pretrial efficiency but are resolved individually.
What birth defects are linked to Depakote?
Depakote has been linked to spina bifida, heart defects, cleft palate, limb abnormalities, and cognitive delays.
Fetal valproate syndrome, a pattern of facial and developmental abnormalities, is also associated with prenatal exposure.
The risk of major birth defects is estimated at 10% to 15% for babies exposed during the first trimester.
The Depakote lawsuit in 2026 remains one of the most significant pharmaceutical litigations in the country. Families affected by birth defects and adults harmed by serious side effects still have the opportunity to seek justice and compensation.
Check your eligibility now. Gather your medical records. Reach out to a qualified pharmaceutical litigation attorney who handles Depakote cases.
The window to file is open, but statutes of limitations are ticking in every state. Acting sooner gives your case the strongest possible foundation.
